In a filing, Anavex Life Sciences Corporation revealed its Director Donhauser Peter D.O. acquired Company’s shares for reported $10319.0 on Jun 14 ’24. In the deal valued at $3.64 per share,2,835 shares were bought. As a result of this transaction, Donhauser Peter D.O. now holds 5,000 shares worth roughly $41150.0.
Then, Thomas Steffen bought 5,000 shares, generating $22,600 in total proceeds. Upon buying the shares at $4.52, the Director now owns 5,000 shares.
Cantor Fitzgerald downgraded its Anavex Life Sciences Corporation [AVXL] rating to a Neutral from a an Overweight in a research note published on December 06, 2022; the price target was decreased to $11 from $16. A number of analysts have revised their coverage, including Berenberg’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. BTIG Research began covering AVXL with “Buy” recommendation on September 23, 2021. H.C. Wainwright maintained its rating on December 16, 2020. It rated AVXL as “a Buy”.
Price Performance Review of AVXL
On Tuesday, Anavex Life Sciences Corporation [NASDAQ:AVXL] saw its stock fall -7.63% to $8.23. Over the last five days, the stock has lost -14.54%. Anavex Life Sciences Corporation shares have fallen nearly -23.37% since the year began. Nevertheless, the stocks have risen 118.88% over the past one year. While a 52-week high of $14.44 was reached on 01/07/25, a 52-week low of $3.51 was recorded on 04/09/25. SMA at 50 days reached $8.89, while 200 days put it at $7.93.
Levels Of Support And Resistance For AVXL Stock
The 24-hour chart illustrates a support level at 8.02, which if violated will result in even more drops to 7.82. On the upside, there is a resistance level at 8.61. A further resistance level may holdings at 9.00. The Relative Strength Index (RSI) on the 14-day chart is 38.38, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.13%. Stochastics %K at 30.44% indicates the stock is a holding.
The most recent change occurred on September 28, 2020 when Ladenburg Thalmann began covering the stock and recommended ‘”a Buy”‘ rating along with a $12 price target.
